EdgarLookup

HUNTINGTON BANCSHARES INC /MD/ — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that HUNTINGTON BANCSHARES INC /MD/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
141.5%
Profit Margin
Net income ÷ revenue
1%
Return on Assets
Net income ÷ assets
8.25x
Debt-to-Equity
Total liabilities ÷ equity
+6.4%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.56B Feb 13, 2026
FY2025 Dec 31, 2024 $1.47B Feb 13, 2026
FY2025 Dec 31, 2023 $1.40B Feb 13, 2026
FY2024 Dec 31, 2022 $1.32B Feb 14, 2025
FY2023 Dec 31, 2021 $1.11B Feb 16, 2024
FY2022 Dec 31, 2020 $884.00M Feb 17, 2023
FY2021 Dec 31, 2019 $939.00M Feb 18, 2022
FY2020 Dec 31, 2018 $881.00M Feb 26, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.21B Feb 13, 2026
FY2025 Dec 31, 2024 $1.94B Feb 13, 2026
FY2025 Dec 31, 2023 $1.95B Feb 13, 2026
FY2024 Dec 31, 2022 $2.24B Feb 14, 2025
FY2023 Dec 31, 2021 $1.30B Feb 16, 2024
FY2022 Dec 31, 2020 $817.00M Feb 17, 2023
FY2019 Dec 31, 2019 $317.00M Feb 14, 2020
FY2019 Sep 30, 2019 $372.00M Feb 14, 2020
FY2019 Jun 30, 2019 $364.00M Feb 14, 2020
FY2019 Mar 31, 2019 $358.00M Feb 14, 2020

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $225.11B Feb 13, 2026
FY2025 Dec 31, 2024 $204.23B Feb 13, 2026
FY2024 Dec 31, 2023 $189.37B Feb 14, 2025
FY2023 Dec 31, 2022 $182.91B Feb 16, 2024
FY2022 Dec 31, 2021 $174.06B Feb 17, 2023
FY2021 Dec 31, 2020 $123.04B Feb 18, 2022
FY2020 Dec 31, 2019 $109.00B Feb 26, 2021
FY2019 Dec 31, 2018 $108.78B Feb 14, 2020
FY2018 Dec 31, 2017 $104.19B Feb 15, 2019
FY2017 Dec 31, 2016 $99.71B Feb 16, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $200.73B Feb 13, 2026
FY2025 Dec 31, 2024 $184.45B Feb 13, 2026
FY2024 Dec 31, 2023 $169.97B Feb 14, 2025
FY2023 Dec 31, 2022 $165.14B Feb 16, 2024
FY2022 Dec 31, 2021 $154.75B Feb 17, 2023
FY2021 Dec 31, 2020 $110.05B Feb 18, 2022
FY2020 Dec 31, 2019 $97.21B Feb 26, 2021
FY2019 Dec 31, 2018 $97.68B Feb 14, 2020
FY2018 Dec 31, 2017 $93.37B Feb 15, 2019
FY2017 Dec 31, 2016 $89.41B Feb 16, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $24.34B Feb 13, 2026
FY2025 Dec 31, 2024 $19.74B Feb 13, 2026
FY2024 Dec 31, 2023 $19.35B Feb 14, 2025
FY2023 Dec 31, 2022 $17.73B Feb 16, 2024
FY2022 Dec 31, 2021 $19.30B Feb 17, 2023
FY2021 Dec 31, 2020 $12.99B Feb 18, 2022
FY2020 Dec 31, 2019 $11.80B Feb 26, 2021
FY2020 Dec 31, 2018 $11.10B Feb 26, 2021
FY2020 Dec 31, 2017 $10.81B Feb 26, 2021
FY2019 Dec 31, 2016 $10.31B Feb 14, 2020

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 13, 2026
FY2025 Dec 31, 2024 1 Feb 13, 2026
FY2025 Dec 31, 2023 1 Feb 13, 2026
FY2024 Dec 31, 2022 1 Feb 14, 2025
FY2023 Dec 31, 2021 0 Feb 16, 2024
FY2022 Dec 31, 2020 0 Feb 17, 2023
FY2019 Dec 31, 2019 0 Feb 14, 2020
FY2019 Sep 30, 2019 0 Feb 14, 2020
FY2019 Jun 30, 2019 0 Feb 14, 2020
FY2019 Mar 31, 2019 0 Feb 14, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 13, 2026
FY2025 Dec 31, 2024 1 Feb 13, 2026
FY2025 Dec 31, 2023 1 Feb 13, 2026
FY2024 Dec 31, 2022 1 Feb 14, 2025
FY2023 Dec 31, 2021 0 Feb 16, 2024
FY2022 Dec 31, 2020 0 Feb 17, 2023
FY2019 Dec 31, 2019 0 Feb 14, 2020
FY2019 Sep 30, 2019 0 Feb 14, 2020
FY2019 Jun 30, 2019 0 Feb 14, 2020
FY2019 Mar 31, 2019 0 Feb 14, 2020

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2018 Dec 31, 2018 $2.67B Feb 15, 2019
FY2018 Dec 31, 2017 $1.52B Feb 15, 2019
FY2018 Dec 31, 2016 $1.39B Feb 15, 2019
FY2018 Dec 31, 2015 $847.00M Feb 15, 2019
FY2017 Dec 31, 2014 $1.22B Feb 16, 2018
FY2016 Dec 31, 2013 $1.00B Feb 22, 2017
FY2015 Dec 31, 2012 $1.26B Feb 17, 2016
FY2014 Dec 31, 2011 $1.26B Feb 13, 2015
FY2014 Dec 31, 2010 $1.12B Feb 13, 2015
FY2010 Dec 31, 2009 $1.52B Feb 18, 2011

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $17.22B Feb 13, 2026
FY2025 Dec 31, 2024 $16.37B Feb 13, 2026
FY2024 Dec 31, 2023 $12.39B Feb 14, 2025
FY2023 Dec 31, 2022 $9.69B Feb 16, 2024
FY2022 Dec 31, 2021 $7.11B Feb 17, 2023
FY2021 Dec 31, 2020 $8.35B Feb 18, 2022
FY2020 Dec 31, 2019 $9.85B Feb 26, 2021
FY2019 Dec 31, 2018 $8.63B Feb 14, 2020
FY2018 Dec 31, 2017 $9.21B Feb 15, 2019
FY2017 Dec 31, 2016 $8.31B Feb 16, 2018